📉 The Financial Deep Dive
Onelife Capital Advisors Limited is embarking on a significant capital raise through a Rights Issue, offering 2,40,00,000 equity shares at ₹15 each to raise ₹36 crore. The funds are earmarked for its subsidiary, Dealmoney Commodities Private Limited, to bolster margin money requirements, alongside general corporate purposes.
However, the company's recent financial performance paints a grim picture. For the fiscal year ending March 31, 2025 (FY25), total income saw a sharp YoY decline of 20.88%, dropping from ₹4,017.06 lakhs in FY24 to ₹3,178.42 lakhs in FY25. This revenue contraction has led to a substantial shift from profitability to loss, with the company reporting a net loss after tax of ₹487.81 lakhs in FY25, a stark contrast to the ₹63.29 lakhs profit recorded in FY24. Consequently, Earnings Per Share (EPS) turned negative, standing at ₹(3.65) for FY25, down from ₹0.47 in FY24. The Return on Net Worth (RoNW) also deteriorated significantly, becoming negative at (13.86)% in FY25 compared to a marginal 1.24% in FY24.
🚩 Risks & Outlook
The primary concern for Onelife Capital Advisors lies in its extensive legal and regulatory entanglements. The Securities and Exchange Board of India (SEBI) has previously imposed monetary penalties and debarred the company and its promoters from participating in the securities market. Further instances of non-compliance with listing regulations have resulted in fines, and the company has faced delays in statutory dues. Adding to these headwinds, the statutory auditors have raised 'Emphasis of Matters' in their reports concerning the recoverability of investments and the impact of ongoing legal proceedings, signalling deep-seated operational and financial fragilities.
The business model, centred around financial advisory services, strategic investments, and integration via a 'Onelifetouch' super app, is currently overshadowed by these risks. The rights issue's focus on supporting the subsidiary's margin trading activities suggests that the core business may be under pressure, necessitating capital injection into its operations. The outlook remains highly uncertain, contingent on the company's ability to navigate its regulatory challenges, improve financial performance, and ensure the recoverability of its investments. Investors should closely monitor any further actions from SEBI and the auditor's future reports.